Chemed Corp: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Jul 31, 2019 and accepted by EDGAR at Jul 31, 2019, 08:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-04-01 to 2019-06-30 | $473.6m | us-gaap:Revenues |
| Revenue | 6 months2019-01-01 to 2019-06-30 | $935.6m | us-gaap:Revenues |
| Cost of revenue | 3 months2019-04-01 to 2019-06-30 | $323.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2019-01-01 to 2019-06-30 | $645.6m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2019-04-01 to 2019-06-30 | $71.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-01-01 to 2019-06-30 | $145.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-04-01 to 2019-06-30 | $65.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | $115.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $1.2m | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $2.4m | us-gaap:InterestExpense |
| Income tax | 3 months2019-04-01 to 2019-06-30 | $13.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-01-01 to 2019-06-30 | $19.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-04-01 to 2019-06-30 | $50.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | $95.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | $3.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | $5.79 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-04-01 to 2019-06-30 | $3.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-01-01 to 2019-06-30 | $5.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-04-01 to 2019-06-30 | 16,449,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-01-01 to 2019-06-30 | 16,489,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $108.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-01-01 to 2019-06-30 | $28.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2019-01-01 to 2019-06-30 | $9.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2019-01-01 to 2019-06-30 | $71.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-06-30 | $3.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $180.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $1.09bn | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $223.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-06-30 | $475.5m | us-gaap:Liabilities |
| Long-term debt | At period end2019-06-30 | $85.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2019-06-30 | $618.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-06-30 | 15,921,808 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000019584-19-000003. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.